• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与抗病毒药物SCH48973复合的2型兰辛脊髓灰质炎病毒的结构:三种脊髓灰质炎病毒血清型的结构和生物学特性比较

Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes.

作者信息

Lentz K N, Smith A D, Geisler S C, Cox S, Buontempo P, Skelton A, DeMartino J, Rozhon E, Schwartz J, Girijavallabhan V, O'Connell J, Arnold E

机构信息

Center for Advanced Biotechnology and Medicine, Piscataway, NJ 08854, USA.

出版信息

Structure. 1997 Jul 15;5(7):961-78. doi: 10.1016/s0969-2126(97)00249-9.

DOI:10.1016/s0969-2126(97)00249-9
PMID:9261087
Abstract

BACKGROUND

Polioviruses are human pathogens and the causative agents of poliomyelitis. Polioviruses are icosahedral single-stranded RNA viruses, which belong to the picornavirus family, and occur as three distinct serotypes. All three serotypes of poliovirus can infect primates, but only type 2 can infect mice. The crystal structures of a type 1 and a type 3 poliovirus are already known. Structural studies of poliovirus type 2 Lansing (PV2L) were initiated to try to enhance our understanding of the differences in host range specificity, antigenicity and receptor binding among the three serotypes of poliovirus.

RESULTS

The crystal structure of the mouse neurovirulent PV2L complexed with a potent antiviral agent, SCH48973, was determined at 2.9 A resolution. Structural differences among the three poliovirus serotypes occur primarily in the loop regions of the viral coat proteins (VPs), most notably in the loops of VP1 that cluster near the fivefold axes of the capsid, where the BC loop of PV2L is disordered. Unlike other known structures of enteroviruses, the entire polypeptide chain of PV2L VP4 is visible in the electron density and RNA bases are observed stacking with conserved aromatic residues (Tyr4020 and Phe4046) of VP4. The broad-spectrum antiviral agent SCH48973 is observed binding in a pocket within the beta-barrel of VP1, in approximately the same location that natural 'pocket factors' bind to polioviruses. SCH48973 forms predominantly hydrophobic interactions with the pocket residues.

CONCLUSIONS

Some of the conformational changes required for infectivity and involved in the control of capsid stability and neurovirulence in mice may occur in the vicinity of the fivefold axis of the poliovirus, where there are significant structural differences among the three poliovirus serotypes in the surface exposed loops of VP1 (BC, DE, and HI). A surface depression is located at the fivefold axis of PV2L that is not present in the other two poliovirus serotypes. The observed interaction of RNA with VP4 supports the observation that loss of VP4 ultimately leads to the loss of viral RNA. A model is proposed that suggests dual involvement of the virion fivefold and pseudo-threefold axes in receptor-mediated initiation of infection by picornaviruses.

摘要

背景

脊髓灰质炎病毒是人类病原体,也是脊髓灰质炎的致病因子。脊髓灰质炎病毒是二十面体单链RNA病毒,属于微小核糖核酸病毒科,有三种不同的血清型。脊髓灰质炎病毒的所有三种血清型都能感染灵长类动物,但只有2型能感染小鼠。1型和3型脊髓灰质炎病毒的晶体结构已为人所知。开展对2型兰辛脊髓灰质炎病毒(PV2L)的结构研究,旨在增进我们对脊髓灰质炎病毒三种血清型在宿主范围特异性、抗原性和受体结合方面差异的理解。

结果

以2.9埃的分辨率确定了与强效抗病毒剂SCH48973复合的小鼠神经毒性PV2L的晶体结构。三种脊髓灰质炎病毒血清型之间的结构差异主要发生在病毒衣壳蛋白(VPs)的环区,最显著的是在衣壳五重轴附近聚集的VP1环区,其中PV2L的BC环无序。与其他已知的肠道病毒结构不同,PV2L VP4的整个多肽链在电子密度图中可见,并且观察到RNA碱基与VP4的保守芳香族残基(Tyr4020和Phe4046)堆积。观察到广谱抗病毒剂SCH48973结合在VP1β桶内的一个口袋中,位置与天然“口袋因子”结合脊髓灰质炎病毒的位置大致相同。SCH48973主要与口袋残基形成疏水相互作用。

结论

感染所需的以及参与小鼠衣壳稳定性和神经毒性控制的一些构象变化可能发生在脊髓灰质炎病毒五重轴附近,在VP1(BC、DE和HI)表面暴露环区,三种脊髓灰质炎病毒血清型在此处存在显著结构差异。PV2L的五重轴处有一个表面凹陷,其他两种脊髓灰质炎病毒血清型中不存在。观察到的RNA与VP4的相互作用支持了VP4缺失最终导致病毒RNA缺失的观点。提出了一个模型,表明病毒体五重轴和假三重轴在微小核糖核酸病毒受体介导的感染起始中起双重作用。

相似文献

1
Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes.与抗病毒药物SCH48973复合的2型兰辛脊髓灰质炎病毒的结构:三种脊髓灰质炎病毒血清型的结构和生物学特性比较
Structure. 1997 Jul 15;5(7):961-78. doi: 10.1016/s0969-2126(97)00249-9.
2
The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle.人鼻病毒16型在2.15埃分辨率下的精细结构:对病毒生命周期的影响。
Structure. 1997 Mar 15;5(3):427-41. doi: 10.1016/s0969-2126(97)00199-8.
3
The structure of coxsackievirus B3 at 3.5 A resolution.柯萨奇病毒B3在3.5埃分辨率下的结构。
Structure. 1995 Jul 15;3(7):653-67. doi: 10.1016/s0969-2126(01)00201-5.
4
Human rhinovirus 3 at 3.0 A resolution.分辨率为3.0埃的人鼻病毒3型。
Structure. 1996 Oct 15;4(10):1205-20. doi: 10.1016/s0969-2126(96)00128-1.
5
H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1.H1PVAT是一种新型强效的脊髓灰质炎病毒复制早期抑制剂,其作用靶点为VP1。
Antiviral Res. 2014 Oct;110:1-9. doi: 10.1016/j.antiviral.2014.07.003. Epub 2014 Jul 17.
6
The crystal structure of coxsackievirus A9: new insights into the uncoating mechanisms of enteroviruses.柯萨奇病毒A9的晶体结构:对肠道病毒脱壳机制的新见解
Structure. 1999 Dec 15;7(12):1527-38. doi: 10.1016/s0969-2126(00)88343-4.
7
Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design.脊髓灰质炎病毒与抗病毒药物复合物的结构:对病毒稳定性和药物设计的启示。
Curr Biol. 1994 Sep 1;4(9):784-97. doi: 10.1016/s0960-9822(00)00176-7.
8
Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating functions.3型脊髓灰质炎病毒耐药性突变的分布确定了三个参与脱壳功能的区域。
J Virol. 1994 Dec;68(12):8193-201. doi: 10.1128/JVI.68.12.8193-8201.1994.
9
Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing.2型兰辛株脊髓灰质炎病毒小鼠神经毒力所需序列的定位
J Virol. 1986 Feb;57(2):515-25. doi: 10.1128/JVI.57.2.515-525.1986.
10
The structure and antigenicity of a type C foot-and-mouth disease virus.一种C型口蹄疫病毒的结构与抗原性
Structure. 1994 Feb 15;2(2):123-39. doi: 10.1016/s0969-2126(00)00014-9.

引用本文的文献

1
Degradation of Poliovirus Sabin 2 Genome After Electron Beam Irradiation.脊髓灰质炎病毒萨宾2型基因组在电子束辐照后的降解
Vaccines (Basel). 2025 Jul 31;13(8):824. doi: 10.3390/vaccines13080824.
2
Poliovirus shedding after sequential immunization of Sabin-strain inactivated polio vaccines and oral attenuated polio vaccines.在接种萨宾株灭活脊髓灰质炎疫苗和口服减毒脊髓灰质炎疫苗后脊髓灰质炎病毒的排出情况
NPJ Vaccines. 2025 Apr 23;10(1):81. doi: 10.1038/s41541-025-01134-9.
3
Endosome rupture enables enteroviruses from the family Picornaviridae to infect cells.
内体破裂使小核糖核酸病毒科的肠道病毒能够感染细胞。
Commun Biol. 2024 Nov 8;7(1):1465. doi: 10.1038/s42003-024-07147-9.
4
Vaccine Potency and Structure of Yeast-Produced Polio Type 2 Stabilized Virus-like Particles.酵母生产的脊髓灰质炎2型稳定病毒样颗粒的疫苗效力与结构
Vaccines (Basel). 2024 Sep 20;12(9):1077. doi: 10.3390/vaccines12091077.
5
Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?是否到了改用其他减毒活疫苗而非口服脊髓灰质炎减毒活疫苗来预防脊髓灰质炎的时候了?
Front Public Health. 2024 Jan 8;11:1284337. doi: 10.3389/fpubh.2023.1284337. eCollection 2023.
6
A human monoclonal antibody binds within the poliovirus receptor-binding site to neutralize all three serotypes.一种人源单克隆抗体与脊髓灰质炎病毒受体结合位点结合,从而中和所有三个血清型。
Nat Commun. 2023 Oct 10;14(1):6335. doi: 10.1038/s41467-023-41052-9.
7
Identification of the Intrinsic Motions and Related Key Residues Responsible for the Twofold Channel Opening of Poliovirus Capsid by Using an Elastic Network Model Combined with an Internal Coordinate.结合内部坐标使用弹性网络模型鉴定脊髓灰质炎病毒衣壳双重通道开放的内在运动及相关关键残基
ACS Omega. 2022 Dec 16;8(1):782-790. doi: 10.1021/acsomega.2c06114. eCollection 2023 Jan 10.
8
A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation.脊髓灰质炎病毒中保守的谷胱甘肽结合位点是抗病毒药物和疫苗稳定剂的作用靶点。
Commun Biol. 2022 Nov 25;5(1):1293. doi: 10.1038/s42003-022-04252-5.
9
Cryo-electron microscopy and image classification reveal the existence and structure of the coxsackievirus A6 virion.冷冻电子显微镜和图像分类揭示了柯萨奇病毒 A6 病毒粒子的存在和结构。
Commun Biol. 2022 Sep 2;5(1):898. doi: 10.1038/s42003-022-03863-2.
10
Rhinovirus Inhibitors: Including a New Target, the Viral RNA.鼻病毒抑制剂:包括一个新的靶点,病毒 RNA。
Viruses. 2021 Sep 7;13(9):1784. doi: 10.3390/v13091784.